Education > XRAY > Search Results

FORCE's eXaming the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

31 through 40 of 212

Relevance: High

pointerRelevance

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Update : New FDA approval of PARP inhibitor for maintenance therapy in ovarian cancer

Most relevant for: People with advanced ovarian cancer who have had a complete or partial response to chemotherapy

The FDA has approved the use of niraparib (Zejula) as a maintenance therapy for women with advanced ovarian cancer who have had a complete or partial response to chemotherapy. (5/7/20)

Read More
New FDA approval of PARP inhibitor for maintenance therapy in ovarian cancer

Relevance: High

pointerRelevance

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Update : FDA approves tucatinib (Tukysa) for metastatic Her2-positive breast cancer

Most relevant for: Patients with Her2-positive metastatic breast cancer

The FDA has approved the use of tucatinib (Tukysa) in combination with chemotherapy as a treatment for people with metastatic Her2-positive breast cancer. This  approval includes treatment of people whose breast cancer has spread to the brain. (4/29/20)

Read More
FDA approves tucatinib (Tukysa) for metastatic Her2-positive breast cancer

Relevance: High

pointerRelevance

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Update : FDA approves new treatment for metastatic triple-negative breast cancer

Most relevant for: People with metastatic triple-negative breast cancer who have received at least two prior lines of treatment

The FDA approved the use of sacituzumab govitecan-hizy (Trodelvy), a treatment drug for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. (4/27/20)

Read More
FDA approves new treatment for metastatic triple-negative breast cancer

Topic : COVID-19 and cancer

Most relevant for: People in treatment for cancer, or people scheduled for surgery

The current COVID-19 pandemic has led to many changes in our communities. In this XRAY review we focus on the intersection between COVID-19 and cancer: who may be immunosuppressed, coping with changes in surveillance or treatment, and evaluating and dealing with media. (4/13/20)

Este artículo está disponible en español.

Read More
COVID-19 and cancer

Relevance: High

pointerRelevance

Quality of Writing: High

pointerQuality of Writing
View Related Clinical Trials

Personal Story : Improving the quality of life for people with metastatic breast cancer

Most relevant for: People diagnosed with metastatic breast cancer

Washington Post article described the cancer experience of a young woman living with metastatic breast cancer. It also highlights how integrative medicine and palliative care, including acupuncture, massage, yoga, pain management, mental health therapy and nutrition can improve quality of life for people with metastatic cancer. (3/10/20)

Este artículo está disponible en español.

Read More
Improving the quality of life for people with metastatic breast cancer

Relevance: Medium

pointerRelevance

Strength of Science: Medium

pointerStrength of Science
View Related Clinical Trials

Study : Can taking dietary supplements during chemotherapy do more harm than good?

Most relevant for: People undergoing breast cancer treatment with chemotherapy

It's common for people to take dietary supplements after being diagnosed with cancer; however, they may reduce how well chemotherapy works. A new study suggests that some dietary supplements may cause more harm than benefit for breast cancer patients who are undergoing chemotherapy. (3/4/20)

Read More
Can taking dietary supplements during chemotherapy do more harm than good?

Relevance: High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science
View Related Clinical Trials

Study : Racial and ethnic differences in genetic testing among young breast cancer survivors

Most relevant for: Women diagnosed with breast cancer at age 50 or younger

Genetic testing is recommended for most women who are diagnosed with breast cancer at age 50 or younger.  In this study of young women with breast cancer, while the rates of genetic testing  did not differ, the rates of women testing positive for an inherited mutation associated with breast cancer did vary between racial and ethnic groups. (2/27/20)

Este artículo está disponible en español.

Read More
Racial and ethnic differences in genetic testing among young breast cancer survivors

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Research Timeline: Human Research

pointerResearch Timeline
View Related Clinical Trials

Study : Cancer risk associated with inherited mutations in Lynch syndrome genes

Most relevant for: People with Lynch syndrome mutations

Lynch syndrome is the most common inherited cause of cancer affecting about 1 in 300 people. People with Lynch syndrome have an increased risk of colorectal endometrial and other cancers. A large study followed people with mutations in the Lynch syndrome genes MLH1, MSH2, MSH6 and PMS2 to determine the risk of other types of cancer. (2/21/20)

Read More
Cancer risk associated with inherited mutations in Lynch syndrome genes

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-Low

pointerStrength of Science
View Related Clinical Trials

Study : Do hair dyes or straighteners increase breast cancer risk?

Most relevant for: Young women who use hair dye or straighteners

Many women use products to color or straighten their hair. A large U.S. study linked the use of permanent hair dye and straighteners to increased breast cancer risk, particularly among black women. This XRAY reviews the limitations of this study and highlights the need for additional research before accepting these conclusions. (1/29/20)

Read More
Do hair dyes or straighteners increase breast cancer risk?

Relevance: High

pointerRelevance

Strength of Science: High

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : Second surgery may not benefit women with recurrent ovarian cancer

Most relevant for: Women with recurrent ovarian cancer

Many women who have recurrent ovarian cancer have a second surgery. A new study suggests that women with platinum sensitive cancers who get chemotherapy alone may do as well as or better than women who have surgery followed by chemotherapy. (1/21/20)

Read More
Second surgery may not benefit women with recurrent ovarian cancer